论文信息 - Circulating tumor DNA in unresectable pancreatic cancer is a strong predictor of first-line treatment efficacy: The KRASCIPANC prospective study. - 字舞流文

Circulating tumor DNA in unresectable pancreatic cancer is a strong predictor of first-line treatment efficacy: The KRASCIPANC prospective study.

P. Ingrand | J. Goujon | D. Tougeron | A. Ferru | G. Tachon | V. Randrian | C. Evrard | M. Martel | L. Karayan‐Tapon | Tristan Rochelle | P. Haineaux | Nicolas Flores